These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 20651198)

  • 1. Effect of IV contrast medium on renal function in oncologic patients undergoing CT in ICU.
    Ng CS; Shaw AD; Bell CS; Samuels JA
    AJR Am J Roentgenol; 2010 Aug; 195(2):414-22. PubMed ID: 20651198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iso-osmolality versus low-osmolality iodinated contrast medium at intravenous contrast-enhanced CT: effect on kidney function.
    Nguyen SA; Suranyi P; Ravenel JG; Randall PK; Romano PB; Strom KA; Costello P; Schoepf UJ
    Radiology; 2008 Jul; 248(1):97-105. PubMed ID: 18483232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of contrast-induced nephropathy for patients receiving intravenous vs. intra-arterial iodixanol administration.
    Tong GE; Kumar S; Chong KC; Shah N; Wong MJ; Zimmet JM; Wang ZJ; Yee J; Fu Y; Yeh BM
    Abdom Radiol (NY); 2016 Jan; 41(1):91-9. PubMed ID: 26830615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Intravenous Administration of Contrast Media on Serum Creatinine Levels in Neonates.
    Bedoya MA; White AM; Edgar JC; Pradhan M; Raab EL; Meyer JS
    Radiology; 2017 Aug; 284(2):530-540. PubMed ID: 28387639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Background fluctuation of kidney function versus contrast-induced nephrotoxicity.
    Bruce RJ; Djamali A; Shinki K; Michel SJ; Fine JP; Pozniak MA
    AJR Am J Roentgenol; 2009 Mar; 192(3):711-8. PubMed ID: 19234268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate.
    McDonald JS; McDonald RJ; Carter RE; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Apr; 271(1):65-73. PubMed ID: 24475854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iodixanol: risk of subsequent contrast nephropathy in cancer patients with underlying renal insufficiency undergoing diagnostic computed tomography examinations.
    Cheruvu B; Henning K; Mulligan J; Klippenstein D; Lawrence D; Gurtoo L; Gottlieb RH
    J Comput Assist Tomogr; 2007; 31(4):493-8. PubMed ID: 17882021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the nephrotoxicity of iodixanol in patients with predisposing factors to contrast medium induced nephropathy referred for contrast enhanced computed tomography.
    Sandstede JJ; Roth A; Machann W; Kaupert C; Hahn D
    Eur J Radiol; 2007 Jul; 63(1):120-3. PubMed ID: 17317065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
    Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
    Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrast material-induced nephrotoxicity and intravenous low-osmolality iodinated contrast material: risk stratification by using estimated glomerular filtration rate.
    Davenport MS; Khalatbari S; Cohan RH; Dillman JR; Myles JD; Ellis JH
    Radiology; 2013 Sep; 268(3):719-28. PubMed ID: 23579046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidences of acute kidney injury, dialysis, and graft loss following intravenous administration of low-osmolality iodinated contrast in patients with kidney transplants.
    Fananapazir G; Troppmann C; Corwin MT; Nikpour AM; Naderi S; Lamba R
    Abdom Radiol (NY); 2016 Nov; 41(11):2182-2186. PubMed ID: 27377897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of reduced renal function after contrast-enhanced CT: a model based on serum creatinine level, patient age, and estimated glomerular filtration rate.
    Herts BR; Schneider E; Obuchowski N; Poggio E; Jain A; Baker ME
    AJR Am J Roentgenol; 2009 Aug; 193(2):494-500. PubMed ID: 19620448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nephrotoxic Polypharmacy and Risk of Contrast Medium-Induced Nephropathy in Hospitalized Patients Undergoing Contrast-Enhanced CT.
    Ho YF; Hsieh KL; Kung FL; Wu FL; Hsieh LL; Chou H; Chen SJ
    AJR Am J Roentgenol; 2015 Oct; 205(4):703-8. PubMed ID: 26397318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of cystatin C and serum creatinine for the diagnosis of contrast-induced nephropathy in patients undergoing contrast-enhanced computed tomography at an oncology centre.
    Fortalesa Melo JI; Chojniak R; Costa Silva DH; Oliveira Junior JC; Vieira Bitencourt AG; Holanda Silva D; Guimarães MD; Silva HC; Dias DG; Rodrigues WC; Brancucci EL; Cruz BM; Schiavon BN; Argenton JL; Camporini MA; Zocchio A
    PLoS One; 2015; 10(5):e0122877. PubMed ID: 25961558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravenous low-osmolality iodinated contrast media on patients with myasthenia gravis.
    Somashekar DK; Davenport MS; Cohan RH; Dillman JR; Ellis JH
    Radiology; 2013 Jun; 267(3):727-34. PubMed ID: 23360741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast medium-induced acute kidney injury: comparison of intravenous and intraarterial administration of iodinated contrast medium.
    Karlsberg RP; Dohad SY; Sheng R;
    J Vasc Interv Radiol; 2011 Aug; 22(8):1159-65. PubMed ID: 21570871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous contrast material exposure is not an independent risk factor for dialysis or mortality.
    McDonald RJ; McDonald JS; Carter RE; Hartman RP; Katzberg RW; Kallmes DF; Williamson EE
    Radiology; 2014 Dec; 273(3):714-25. PubMed ID: 25203000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of Split Renal Function Using a Combination of Contrast-Enhanced CT and Serum Creatinine Values for Glomerular Filtration Rate Estimation.
    Shi W; Liang X; Wu N; Zhang H; Yuan X; Tan Y
    AJR Am J Roentgenol; 2020 Jul; 215(1):142-147. PubMed ID: 32255686
    [No Abstract]   [Full Text] [Related]  

  • 19. Persistent renal enhancement after intra-arterial versus intravenous iodixanol administration.
    Chou SH; Wang ZJ; Kuo J; Cabarrus M; Fu Y; Aslam R; Yee J; Zimmet JM; Shunk K; Elicker B; Yeh BM
    Eur J Radiol; 2011 Nov; 80(2):378-86. PubMed ID: 21470810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels.
    Herts BR; Schneider E; Poggio ED; Obuchowski NA; Baker ME
    Radiology; 2008 Jul; 248(1):106-13. PubMed ID: 18458249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.